PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-623

Hi QQ,
I think you made a great point by saying the Scientific Data has been deliberately and meticulously compiled. The more verifiable and proven data the more risk removed for a potential buyer. Additionally PAA have commenced the FDA approval application for Canine use, If they can get approval or at lest show the process is well progressed the same result. Eg less risk for the buyer.

One thing we know for sure is they plan to secure a commercial canine deal this year. [Refer Video last November] That will be a great cornerstone should it come off, and as we know it works from the P2 and P2b trials we have great reason to be confidant.

What was it those 2 young fellas Buffett and Munger say about controlling emotions

Pete